Organic compounds -- part of the class 532-570 series – Organic compounds – Cyclopentanohydrophenanthrene ring system containing
Reexamination Certificate
2001-05-29
2002-05-14
Qazi, Sabiha (Department: 1616)
Organic compounds -- part of the class 532-570 series
Organic compounds
Cyclopentanohydrophenanthrene ring system containing
C552S521000, C552S506000, C552S507000, C552S527000, C552S540000, C552S542000, C552S544000, C552S548000, C552S550000, C552S552000, C552S554000, C552S557000, C552S559000, C552S582000, C552S584000, C552S583000, C552S599000, C514S182000, C514S171000
Reexamination Certificate
active
06388108
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to newly isolated aminosterol compounds. Such aminosterol compounds are useful in a variety of pharmaceutical compositions as well as methods of treatment of various disorders such as, for example, a microbial infection.
2. Description of the Related Art
Over the past several years an increasing number of low molecular weight antibiotics have been isolated from diverse species of vertebrate animals such as frogs (Zasloff, 1987), pigs (Lee et al., 1989), mice (Ouellette et al., 1989) and humans (Jones et al., 1992). These antibiotic agents, including peptides (Steiner et al., 1981; Ganz et al., 1985; Zasloff, 1987), lipids (Kabara et al., 1977; Bibel et al., 1989) and alkaloids (Daly et al., 1987; Preusser et al., 1975), are believed to play a major role in host defense against environmental microbes.
The search for novel host defense agents led to the discovery of the aminosterol squalamine. Squalamine was isolated from the dogfish shark
Squalus acanthias
and proved to be active as a broad-spectrum antibiotic. U.S. Pat. No. 5,192,756. Squalamine also exhibited interesting antiangiogenic and antitumor properties. Attempts to isolate large amounts of squalamine have now led to the discovery, isolation and purification of several new aminosterol compounds which are the subject of the present invention.
SUMMARY OF THE INVENTION
The invention provides newly isolated aminosterol compounds and pharmaceutically acceptable salts thereof.
The invention further provides pharmaceutical compositions comprising at least one aminosterol compound of the invention or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.
The invention further provides a method of treating a microbial infection comprising administering a therapeutically effective amount of at least one aminosterol compound of the invention or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 5192756 (1993-03-01), Zasloff et al.
patent: 5637691 (1997-06-01), Frye et al.
patent: 5721226 (1998-02-01), Frye et al.
patent: 5733899 (1998-03-01), Frye et al.
patent: 5763430 (1998-06-01), Zasloff
patent: 5840936 (1998-11-01), Zasloff et al.
patent: 6147060 (2000-11-01), Zasloff et al.
patent: 9824800 (1998-06-01), None
Feibush Binyamin
Kinney William
Noecker Lincoln
Rao Meena
Zasloff Michael
Genaera Corporation
Qazi Sabiha
LandOfFree
Aminosterol compounds and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminosterol compounds and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminosterol compounds and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2870815